If you have a business interest in North American Adoptive T-Cell Therapies, or looking to network with senior executives and influencers within the space, learn more about the North American Adoptive T-Cell Therapies, taking place this June 28, 2016, Boston, US.

Here’s a quick look at the North American Adoptive T-Cell Therapies Congress Workshop Day Agenda:

For the full speaker list with session details, download the full brochure now.

download-btn-sld

Time of Session
Workshops ASession SpeakersWorkshops BSession Speakers
8:30
Registration Opens for Workshops A and B
9:00
T-Cell based treatment of inflammation: antigen-specific Treg cells, TCR and CAR engineered Treg cells in transplantation, autoimmunity and chronic inflammatory diseases
Arnaud Foussat, Chief Scientific Officer, TXCELL SASecond Generation CAR-T and TCR Approaches for Enhancing Efficacy and DurabilityPeter Hoang, SVP, Business Development and Strategy, BELLICUM
12:00
Networking Lunch for All Workshop Attendees
12:30
Registration Opens for Workshops C and D
Workshops CSession SpeakersWorkshops DSession Speakers
13:00
CAR T-Cell Workshop Personalized or off-the shelf CAR T-Cells: Will there be a winner or is there room for both?Sicco Popma, Scientific Director and leader of Gene-Modified Cell Therapies at JBIO (JANSSEN R&D)Approaches to Re-Imbursement of Adoptive Cell Therapy – with Professor Robert Hawkins, Chief Executive Officer and Co-founder of Cellular Therapeutics Ltd, CRUK Chair of Medical Oncology at The University of Manchester & Consultant in Medical Oncology at The Christie NHS Foundation Trust

For the full speaker list with session details, download the full brochure now.

download-btn-sld